{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,4]],"date-time":"2022-04-04T12:49:12Z","timestamp":1649076552540},"reference-count":33,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2003,12,1]],"date-time":"2003-12-01T00:00:00Z","timestamp":1070236800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Surgical Oncology (EJSO)"],"published-print":{"date-parts":[[2003,12]]},"DOI":"10.1016\/j.ejso.2003.09.004","type":"journal-article","created":{"date-parts":[[2003,10,24]],"date-time":"2003-10-24T22:11:49Z","timestamp":1067033509000},"page":"904-907","source":"Crossref","is-referenced-by-count":1,"title":["FHIT mRNA expression in thymoma"],"prefix":"10.1016","volume":"29","author":[{"given":"H.","family":"Sasaki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Yukiue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Yano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Fukai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.","family":"Fujii","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejso.2003.09.004_BIB1","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/S0046-8177(78)80131-2","article-title":"Thymic hyperplasia and neoplasia: a review of current concepts","volume":"9","author":"Levine","year":"1978","journal-title":"Hum Pathol"},{"key":"10.1016\/j.ejso.2003.09.004_BIB2","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1001\/archinte.1974.00320200184029","article-title":"The spectrum of disease associated with thymoma: coincidence or syndrome?","volume":"134","author":"Souadjian","year":"1974","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ejso.2003.09.004_BIB3","series-title":"Tumors of the thymus, Atlas of Tumor Pathology","author":"Rosai","year":"1976"},{"key":"10.1016\/j.ejso.2003.09.004_BIB4","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1002\/1097-0142(19811201)48:11<2485::AID-CNCR2820481123>3.0.CO;2-R","article-title":"Follow-up study of thymomas with special reference to their clinical stages","volume":"48","author":"Masaoka","year":"1981","journal-title":"Cancer"},{"key":"10.1016\/j.ejso.2003.09.004_BIB5","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/S0092-8674(00)81034-X","article-title":"The FHIT gene, spanning the chromosome 3p14.2 g fragile site and renal carcinoma-associated t (3:8) breakpoint, is abnormal indigestive tract cancers","volume":"84","author":"Ohta","year":"1996","journal-title":"Cell"},{"key":"10.1016\/j.ejso.2003.09.004_BIB6","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0092-8674(00)81078-8","article-title":"The FHIT gene 3p14.2 is abnormal in lung cancer","volume":"85","author":"Sozzi","year":"1996","journal-title":"Cell"},{"key":"10.1016\/j.ejso.2003.09.004_BIB7","first-page":"5207","article-title":"Absence of Fhit protein in primary lung tumor and cell lines with FHIT gene abnormalities","volume":"57","author":"Sozzi","year":"1997","journal-title":"Cancer Res"},{"key":"10.1016\/j.ejso.2003.09.004_BIB8","first-page":"4798","article-title":"Loss of Fhit is frequent in stage I non-small cell lung cancer and in the lungs of chronic smokers","volume":"59","author":"Tseng","year":"1999","journal-title":"Cancer Res"},{"key":"10.1016\/j.ejso.2003.09.004_BIB9","first-page":"2256","article-title":"FHIT and FRA3B 3p14.2 allele loss are common in lung cancer and preneoplastic bronchial lesions and are associated with cancer-related FHIT cDNA splicing aberrations","volume":"57","author":"Fong","year":"1997","journal-title":"Cancer Res"},{"key":"10.1016\/j.ejso.2003.09.004_BIB10","first-page":"3173","article-title":"The FHIT gene at 3p14.2 is abnormal in breast carcinomas","volume":"56","author":"Negrini","year":"1996","journal-title":"Cancer Res"},{"key":"10.1016\/j.ejso.2003.09.004_BIB11","first-page":"3664","article-title":"Analysis of the FHIT gene and FRA3B region in sporadic breast cancer, preneoplastic lesions, and familial breast cancer probands","volume":"57","author":"Ahmadian","year":"1997","journal-title":"Cancer Res"},{"key":"10.1016\/j.ejso.2003.09.004_BIB12","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1016\/S0002-9440(10)63031-3","article-title":"Thymic epithelial tumor can develop along two different pathogenetic pathways","volume":"159","author":"Zhou","year":"2001","journal-title":"Am J Pathol"},{"key":"10.1016\/j.ejso.2003.09.004_BIB13","first-page":"5032","article-title":"Loss of FHIT function in lung cancer and preinvasive bronchial lesions","volume":"58","author":"Sozzi","year":"1998","journal-title":"Cancer Res"},{"key":"10.1016\/j.ejso.2003.09.004_BIB14","first-page":"5478","article-title":"Clinicopathological significance of Fhit protein expression in stage I non-small cell lung carcinoma","volume":"58","author":"Tomizawa","year":"1998","journal-title":"Cancer Res"},{"key":"10.1016\/j.ejso.2003.09.004_BIB15","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1054\/bjoc.1999.1062","article-title":"Loss of Fhit expression in non-small-cell lung cancer: correlation with molecular genetic abnormalities and clinicopathological features","volume":"82","author":"Geradt","year":"2000","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ejso.2003.09.004_BIB16","first-page":"3866","article-title":"FHIT loss of function in human primary breast cancer correlates with advanced stage of the disease","volume":"59","author":"Campiglio","year":"1999","journal-title":"Cancer Res"},{"key":"10.1016\/j.ejso.2003.09.004_BIB17","doi-asserted-by":"crossref","first-page":"8489","DOI":"10.1073\/pnas.96.15.8489","article-title":"The tumor-suppressor gene FHIT is involved in the regulation of apoptosis and in cell cycle control","volume":"96","author":"Sard","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.ejso.2003.09.004_BIB18","doi-asserted-by":"crossref","first-page":"176","DOI":"10.2144\/97221pf02","article-title":"The LightCycler: a microvolume multisample fluorimeter with rapid temperature control","volume":"22","author":"Wittwer","year":"1997","journal-title":"Biotechniques"},{"key":"10.1016\/j.ejso.2003.09.004_BIB19","doi-asserted-by":"crossref","first-page":"13771","DOI":"10.1073\/pnas.94.25.13771","article-title":"Replacement of Fhit in cancer cells suppresses tumorigenicity","volume":"94","author":"Siprashvili","year":"1997","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.ejso.2003.09.004_BIB20","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/0092-8674(93)90500-P","article-title":"WAF1, a potential mediator of p53 tumor suppression","volume":"75","author":"El-Deiry","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.ejso.2003.09.004_BIB21","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/0092-8674(93)90499-G","article-title":"The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases","volume":"75","author":"Harper","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.ejso.2003.09.004_BIB22","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1038\/366701a0","article-title":"p21 is a universal inhibitor of cyclin kinases","volume":"366","author":"Xiong","year":"1993","journal-title":"Nature (Lond)"},{"key":"10.1016\/j.ejso.2003.09.004_BIB23","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/BF02899381","article-title":"Expression of ras p21 protein by thymoma","volume":"59","author":"Mukai","year":"1990","journal-title":"Virchow Arc Cell Pathol Include Mol Pathol"},{"key":"10.1016\/j.ejso.2003.09.004_BIB24","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/BF00194697","article-title":"Thymoma: tumor type related to expression of epidermal growth factor (EFG), EGF-receptor, p53, v-erb B and ras p21","volume":"426","author":"Hayashi","year":"1995","journal-title":"Virchows Arch"},{"key":"10.1016\/j.ejso.2003.09.004_BIB25","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1046\/j.1365-2559.1997.5730805.x","article-title":"Expression of p53, mdm2, p21\/waf1 and bcl-2 proteins in thymomas","volume":"30","author":"Stefanaki","year":"1997","journal-title":"Histopathology"},{"key":"10.1016\/j.ejso.2003.09.004_BIB26","first-page":"57","article-title":"Retinoblastoma: a prototypic hereditary neoplasm","volume":"5","author":"Knudson","year":"1978","journal-title":"Semin Oncol"},{"key":"10.1016\/j.ejso.2003.09.004_BIB27","first-page":"1804","article-title":"Chromosome 3p14 alterations in lung cancer: evidence that FHIT exon deletion is a target of tobacco carcinogens and asbestos","volume":"58","author":"Nelson","year":"1998","journal-title":"Cancer Res"},{"key":"10.1016\/j.ejso.2003.09.004_BIB28","first-page":"5128","article-title":"Frequent abnormalities of FHIT, a candidate tumor suppressor gene, in head and neck cancer cell lines","volume":"56","author":"Mao","year":"1996","journal-title":"Cancer Res"},{"key":"10.1016\/j.ejso.2003.09.004_BIB29","first-page":"5348","article-title":"Loss of heterozygosity at the familial RCC t (3:8) locus in most clear cell renal carcinomas","volume":"55","author":"Druck","year":"1995","journal-title":"Cancer Res"},{"key":"10.1016\/j.ejso.2003.09.004_BIB30","doi-asserted-by":"crossref","first-page":"9770","DOI":"10.1073\/pnas.93.18.9770","article-title":"FHIT gene alterations in head and neck squamous cell carcinomas","volume":"93","author":"Virgilio","year":"1996","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.ejso.2003.09.004_BIB31","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1038\/nm0795-686","article-title":"5\u2032 CpG island methylation is associated with transcriptional silencing of the tumor suppressor p16\/CDKN2\/MTS1in human cancers","volume":"1","author":"Merlo","year":"1995","journal-title":"Nat Med"},{"key":"10.1016\/j.ejso.2003.09.004_BIB32","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0065-230X(08)60702-2","article-title":"Alterations in DNA methylation: a fundamental aspect of neoplasia","volume":"72","author":"Baylin","year":"1998","journal-title":"Adv Cancer Res"},{"key":"10.1016\/j.ejso.2003.09.004_BIB33","first-page":"3581","article-title":"5\u2032 CpG island methylation of the FHIT gene is correlated with loss of gene expression in lung cancer","volume":"61","author":"Zochbauer-Muller","year":"2001","journal-title":"Cancer Res"}],"container-title":["European Journal of Surgical Oncology (EJSO)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S074879830300204X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S074879830300204X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,3,26]],"date-time":"2020-03-26T07:56:40Z","timestamp":1585209400000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S074879830300204X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,12]]},"references-count":33,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2003,12]]}},"alternative-id":["S074879830300204X"],"URL":"https:\/\/doi.org\/10.1016\/j.ejso.2003.09.004","relation":{},"ISSN":["0748-7983"],"issn-type":[{"value":"0748-7983","type":"print"}],"subject":[],"published":{"date-parts":[[2003,12]]}}}